ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;85:133-134. doi:10.1016/j.athoracsur.2007.08.064
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph Dearani
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dearani, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dearani, J.
Related Collections
Right arrow Cardiac - other
Right arrowRelated Article

Original Articles: Cardiovascular

Invited commentary

Joseph Dearani, MD

Section of Cardiovascular Surgery, Mayo Clinic, 200 First St, SW, Rochester, MN 55905

(Email: jdearani@mayo.edu).

The first 20% of the full text of this article appears below.

It has been 50 years since the initial report of the disease that is now recognized as hypertrophic cardiomyopathy (HCM). During the past 5 decades there have been pendular shifts in the enthusiasm for surgical relief of dynamic outflow obstruction. Improvements in the understanding of the hemodynamics, pathophysiology, and surgical techniques has led to a re-emergence of surgical septal myectomy (SSM) as an appropriate therapy for patients with severe symptoms that were refractory to pharmacologic therapies, which is an indication that has not changed to this day. The SSM has also been challenged by the development and investigation of novel, seemingly "less invasive," yet still interventional therapies: dual-chamber pacing and percutaneous alcohol . . . [Full Text of this Article]


Related Article

Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy
Nicholas G. Smedira, Bruce W. Lytle, Harry M. Lever, Jeevanantham Rajeswaran, Gita Krishnaswamy, Ryan K. Kaple, Diana O.W. Dolney, and Eugene H. Blackstone
Ann. Thorac. Surg. 2008 85: 127-133. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.